MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Purpose

The purpose of this study is to examine how patients with multiple myeloma (MM) have been impacted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The study will use a questionnaire to further understand how patients are being affected and gather information in order to track the long-term effects of the coronavirus. The scope of the questionnaire will include, COVID-19 diagnosis and treatment, changes in myeloma treatment and care, clinical trial familiarity, health and fitness, and quality of life. This questionnaire is a follow-on to the "MM and COVID-19" questionnaire.

Conditions

  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Coronavirus

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Criteria

Inclusion Criteria:

- Adult patients (greater than 18 years) diagnosed with MGUS, smoldering myeloma, and
multiple myeloma.

- Access to a computer or electronic device with internet access, or phone

- Willing to create a patient profile on the HealthTree Cure Hub For Multiple Myeloma

- Willing to give electronically-signed consent

- Ability to read questions in English

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
MGUS, SMM, MM Patients or their Caregivers Eligible participants will be asked to create a free patient profile on the HealthTree Cure Hub (www.healthtree.org) or use their existing patient profile. The creation of a HealthTree Cure Hub patient profile will serve as a screen for eligibility. Patients will complete a one-time questionnaire found on the HealthTree Cure Hub. Telephone assistance can be provided as needed. The questionnaire will take 20-30 minutes to complete.
  • Behavioral: Questionnaire
    Series of questions covering COVID-19 diagnosis and treatment, changes in myeloma treatment and care, clinical trial familiarity, health and fitness, and quality of life.

Recruiting Locations

HealthTree.org (Online)
Lehi, Utah 84043
Contact:
Nathan Sweeney, PhD
800-709-1113
nathan@healthtree.org

More Details

NCT ID
NCT04727294
Status
Unknown status
Sponsor
HealthTree Foundation

Study Contact

Nathan Sweeney, PhD
18007091113
nathan@healthtree.org